Small to mid-market Target the Drug Safety Institute as a smaller to mid-sized player in pharmaceuticals, presenting cost-effective, scalable compliance and safety management solutions tailored for mid-sized teams and growing operations.

Regulatory focus Position offerings around pharmacovigilance, adverse event reporting, and safety data management to align with their core focus on drug safety and regulatory compliance, highlighting seamless integration with existing systems.

Tech stack fit Leverage familiarity with WordPress, PHP and Microsoft 365 to propose lightweight, secure, cloud-based tools or add-ons that integrate with their current stack without heavy re-architecture.

Geographic reach Note potential expansion opportunities from their presence in Miami with ties to Austin data points; offer remote or hybrid solutions that support multi-site operations and cross-regional collaboration.

Growth trajectory With annual revenue in the low single-digit millions and a lean team, present scalable, modular solutions that can grow with them, including pilot programs to demonstrate ROI before broader deployment.